Back to search

Article

SASH3 is an unfavorable prognostic immune biomarker in patients with acute myeloid leukemia(AML).

2023-03-21

Abstract excerpt

<title>Abstract</title> <p>Background: Acute myeloid leukemia(AML) is a malignant clonal disease. As the most common type of leukaemia, it is characterised by poor treatment outcomes and a poor prognosis in both the paediatric and adult populations. Improving anti-tumour responses through immunomodulators is a promising strategy or a new avenue for AML treatment. <h4>Methods:</h4> Using publicly available data f...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ff483db-f00e-5a03-aede-585a621e93f8
DOI
10.21203/rs.3.rs-2664195/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SASH3 is an unfavorable prognostic immune biomarker in patients with acute myeloid leukemia(AML).DOI 10.21203/rs.3.rs-2664195/v1
Select a neighboring publication to make it the new centre.